NIAID Funding News, May 18, 2022

May 18, 2022 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Respond to Just-in-Time Requests and Any Bars to Award Most just-in-time information requested by NIAID staff is routine, but certain codes in your summary statement can indicate an award restriction or bar to award. Opportunities and Resources New Contract Solicitation for Services To Support Developers of Candidate Diagnostics Work with NIAID to provide product developers a discrete subset of services that will propel new in vitro diagnostic products toward regulatory clearance. Conduct Innovative Research on Hepatitis B Virus Cure Further our understanding of unique challenges impacting hepatitis B virus (HBV) and HIV co-infected hosts to advance discovery and development of novel HBV interventions. Accelerate Research on Tickborne Illnesses Through Admin Supplements NIAID will accept administrative supplement applications from current NIAID awardees for research on Lyme disease or other tickborne illnesses, including alpha-gal syndrome. Apply Now for U.S.-India Fellowship Exchange Program A fellowship exchange program for early- and mid-career scientists aims to expand the cohort of physician-scientists that will advance clinical practice and public health in the United States and India. In The News COVID-19 Exception—Post-Submission Materials for January 2023 Council Rounds An exception that allows applicants to send one page with preliminary data as post-submission materials will remain in effect for applications submitted for the January 2023 Council rounds. Identify Challenges and Opportunities in Health and Science Communication Research NIH seeks input from the broader scientific research community on opportunities, challenges, methods, approaches, and technologies to enable the future study of health and science communication. TB Portals Is a Clearinghouse for Tuberculosis Research Data Explore NIAID's digital ecosystem to collate clinical, bacterial genomic, and medical imaging data from tuberculosis patient cases to facilitate data exploration and analysis. Attend Virtual Workshop on Novel Antibacterial and Antifungal Drugs In June, NIAID is hosting a two-day product development virtual workshop to assist academic groups and small start-ups in all stages of antimicrobial product development. An Outage Alert for Grantees Currently Preparing Progress Reports A scheduled update could disrupt completion of in-progress Research Performance Progress Report budget forms if not submitted before June 22, 2022. Advice Corner Obtain Prior Approval Before Altering Your Project You can request some prior approvals using the Prior Approval Module in the eRA Commons. Make your request at least 30 days before you want it to take effect. Reader Questions "In section D.2.c Changes in Other Support of the Research Performance Progress Report, should I list the award for which I am submitting the report?" "Why isn't a single program officer overseeing all my grants?" New Funding Opportunities RFA-AI-22-034, Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development (R01, Clinical Trial Not Allowed) RFA-AI-22-037, Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01, Clinical Trial Not Allowed) PAR-22-109, Dissemination and Implementation Research in Health (R21, Clinical Trial Not Allowed) PAR-22-105, Dissemination and Implementation Research in Health (R01, Clinical Trial Optional) NOT-AI-22-049, Notice of Special Interest (NOSI)—Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and Other NIH Grantees Conducting Research at RBL-Affiliated Sites Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, May 18, 2022 — Add Comment